Alchemab Therapeutics Funding: $82M Raised, Series A (2021)
Alchemab Therapeutics is a Biotech company based in Cambridge, UK. It has raised $82M in total funding. Latest round: Series A.
Alchemab Therapeutics funding overview
Alchemab Therapeutics is a Biotech company based in Cambridge, UK. Alchemab Therapeutics has raised $82M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2021. The round record for Alchemab Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include RA Capital Management.
Alchemab Therapeutics at a glance
Total raised
$82M
Latest round
Series A
Latest round date
January 2021
Industry
Biotech
Headquarters
Cambridge, UK
Notable investors
RA Capital Management
Frequently asked about Alchemab Therapeutics funding
How much has Alchemab Therapeutics raised?
Alchemab Therapeutics has raised $82M in total disclosed funding across the rounds on record.
Who has invested in Alchemab Therapeutics?
RA Capital Management are named among the investors backing Alchemab Therapeutics.
What was the latest Alchemab Therapeutics funding round?
The most recent disclosed round is a Series A, announced in January 2021.
Where is Alchemab Therapeutics based?
Alchemab Therapeutics is based in Cambridge, UK.
What sector does Alchemab Therapeutics operate in?
Alchemab Therapeutics is tracked under Biotech from Cambridge, UK, with $82M in disclosed funding.
When did Alchemab Therapeutics last raise?
The last disclosed Alchemab Therapeutics round closed in January 2021 at Series A.
We update the Alchemab Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Cambridge and their backers are listed below.
